Regulated exopolysaccharide production in Myxococcus xanthus.
Myxococcus xanthus fibrils are cell surface-associated structures composed of roughly equal amounts of polysaccharide and protein. The level of M. xanthus polysaccharide production under different conditions in the wild type and in several mutants known to have alterations in fibril production was investigated. Wild-type exopolysaccharide increased significantly as cells entered the stationary phase of growth or upon addition of Ca2+ to growing cells, and the polysaccharide-induced cells exhibited an enhanced capacity for cell-cell agglutination. The activity of the key gluconeogenic pathway enzyme phosphoenolpyruvate carboxykinase (Pck) also increased under these conditions. Most fibril-deficient mutants failed to produce polysaccharide in a stationary-phase- or Ca2+-dependent fashion. However, regulation of Pck activity was generally unimpaired in these mutant strains. In an stk mutant, which overproduces fibrils, polysaccharide production and Pck activity were constitutively high under the conditions tested. Polysaccharide production increased in most fibril-deficient strains when an stk mutant allele was present, indicating that these fibril-deficient mutants retained the basic cellular components required for fibril polysaccharide production. In contrast to other divalent cations tested, Sr2+ effectively replaced Ca2+ in stimulating polysaccharide production, and either Ca2+ or Sr2+ was required for fruiting-body formation by wild-type cells. By using transmission electron microscopy of freeze-substituted log-phase wild-type cells, fibril material was observed as a cell surface-associated layer of uniform thickness composed of filaments with an ordered structure.
Kim
S H
SH
Department of Botany and Microbiology, University of Oklahoma, Norman, Oklahoma 73019-0245, USA.
Ramaswamy
S
S
Downard
J
J
D000371:Agglutination; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002413:Cations, Divalent / Q000494:pharmacology; D005838:Genotype; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D016941:Myxococcus xanthus / Q000235:genetics / Q000254:growth & development / Q000378:metabolism*; D010641:Phenotype; D019764:Phosphoenolpyruvate Carboxykinase (ATP) / Q000378:metabolism; D011135:Polysaccharides, Bacterial / Q000096:biosynthesis*; D013324:Strontium / Q000494:pharmacology; D013997:Time Factors; D014161:Transduction, Genetic
D002413:Cations, Divalent; D011135:Polysaccharides, Bacterial; D019764:Phosphoenolpyruvate Carboxykinase (ATP); D008274:Magnesium; D002118:Calcium; D013324:Strontium